These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2647398)

  • 1. CDP-choline for the treatment of tardive dyskinesia: a small negative series.
    Gelenberg AJ; Wojcik J; Falk WE; Bellinghausen B; Joseph AB
    Compr Psychiatry; 1989; 30(1):1-4. PubMed ID: 2647398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic dyskinesia with CDP-choline.
    Arranz J; Ganoza C
    Arzneimittelforschung; 1983; 33(7A):1071-3. PubMed ID: 6684469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study.
    Tazaki Y; Sakai F; Otomo E; Kutsuzawa T; Kameyama M; Omae T; Fujishima M; Sakuma A
    Stroke; 1988 Feb; 19(2):211-6. PubMed ID: 3278412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effect of CDP-choline on poststroke hemiplegia employing a double-blind controlled trial. Assessed by a new rating scale for recovery in hemiplegia.
    Hazama T; Hasegawa T; Ueda S; Sakuma A
    Int J Neurosci; 1980; 11(3):211-25. PubMed ID: 7002829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable clinical response to choline in tardive dyskinesia.
    Nasrallah HA; Dunner FJ; Smith RE; McCalley-Whitters M; Sherman AD
    Psychol Med; 1984 Aug; 14(3):697-700. PubMed ID: 6387757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CDP choline in cerebral vasculopathy: clinical evaluation and instrumental semeiology].
    Corso EA; Arena M; Ventimiglia A; Bizzarro G; Campo G; Rodolico F
    Clin Ter; 1982 Aug; 102(4):379-86. PubMed ID: 6754218
    [No Abstract]   [Full Text] [Related]  

  • 7. The value of cytidine-5-diphosphate-choline in the prevention of impairment of memory function after electric convulsive therapy. A double-blind study.
    Ayuso-Gutierrez JL; Saiz-Ruiz J
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(3):243-8. PubMed ID: 6755560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of clinically significant improvement of patients with tardive dyskinesia following phosphatidylcholine therapy.
    Domino EF; May WW; Demetriou S; Mathews B; Tait S; Kovacic B
    Biol Psychiatry; 1985 Nov; 20(11):1189-96. PubMed ID: 2864962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A precursor of phospholipids in the treatment of severe traumatic comas].
    Cohadon F; Richer E; Poletto B
    Neurochirurgie; 1982; 28(4):287-90. PubMed ID: 6759958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Controlled study of the administration of CDP-choline to preterm newborn infants with respiratory distress syndrome].
    Valls i Soler A; Sanjurjo P; Vázquez Cordero C
    An Esp Pediatr; 1988 Jun; 28(6):493-6. PubMed ID: 3195851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of postconcussional symptoms with CDP-choline.
    Levin HS
    J Neurol Sci; 1991 Jul; 103 Suppl():S39-42. PubMed ID: 1940965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A crossover study of lecithin treatment of tardive dyskinesia.
    Gelenberg AJ; Dorer DJ; Wojcik JD; Falk WE; Brotman AW; Leahy L
    J Clin Psychiatry; 1990 Apr; 51(4):149-53. PubMed ID: 2182613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New strategies in the management of Parkinson's disease: a biological approach using a phospholipid precursor (CDP-choline).
    Agnoli A; Ruggieri S; Denaro A; Bruno G
    Neuropsychobiology; 1982; 8(6):289-96. PubMed ID: 7162583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of CDP-choline (Nicholin): efficacy As antidepressant treatment.
    Salvadorini F; Galeone F; Nicotera M; Ombrato M; Saba P
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):513-20. PubMed ID: 810312
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurochemical alterations in methamphetamine-dependent patients treated with cytidine-5'-diphosphate choline: a longitudinal proton magnetic resonance spectroscopy study.
    Yoon SJ; Lyoo IK; Kim HJ; Kim TS; Sung YH; Kim N; Lukas SE; Renshaw PF
    Neuropsychopharmacology; 2010 Apr; 35(5):1165-73. PubMed ID: 20043005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study.
    Gelenberg AJ; Doller-Wojcik JC; Growdon JH
    Am J Psychiatry; 1979 Jun; 136(6):772-6. PubMed ID: 375755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic medication for neuroleptic-induced tardive dyskinesia.
    Tammenmaa IA; McGrath JJ; Sailas E; Soares-Weiser K
    Cochrane Database Syst Rev; 2002; (3):CD000207. PubMed ID: 12137608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover study.
    Libov I; Miodownik C; Bersudsky Y; Dwolatzky T; Lerner V
    J Clin Psychiatry; 2007 Jul; 68(7):1031-7. PubMed ID: 17685739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of ceruletide on tardive dyskinesia: a double-blind placebo-controlled study.
    Matsunaga T; Ohyama S; Takehara S; Kabashima K; Moriyama S; Tsuzuki J; Ikeda H; Suematsu M; Akizuki K; Fujimoto K
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(4):533-9. PubMed ID: 3043555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind evaluation of deanol in tardive dyskinesia.
    Penovich P; Morgan JP; Kerzner B; Karch F; Goldblatt D
    JAMA; 1978 May; 239(19):1997-8. PubMed ID: 347112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.